MSBT.OB: Summary for MEDASORB TECHNOLOGS - Yahoo! Canada Finance

MEDASORB TECHNOLOGS (OTC BB:MSBT.OB) Delayed quote data

Last Trade:	0.179 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.179
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.04 - 0.44
Volume:	0
Avg Vol (3m):	1,017,420
Market Cap:	10.88M
P/E (ttm):	N/A
EPS (ttm):	-0.182
Div & Yield:	N/A (N/A%)

MedaSorb Technologies Corporation (MSBT.OB)

1d 5d 3m 6m 1y 2y 5y

Add MSBT.OB to Portfolio

Download Data

HEADLINES

•	MedaSorb's (MSBT.OB) Answer to Unmet Medical Need Could Be Commercialized This Year
	Marketwire (Mon, Feb 8)

•	MedaSorbs Blockbuster Product Could be Commercialized This Year
	BayStreet Newswire (Thu, Feb 4)

•	MEDASORB TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Wed, Jan 13)

•	MedaSorb Technologies Corporation to Present at the Biotech Showcase(TM) 2010
	Marketwire (Mon, Jan 11)

•	MEDASORB TECHNOLOGIES CORP Financials
	EDGAR Online Financials (Thu, Nov 19)

•	MedaSorb Technologies Corporation Provides Clinical Update
	Marketwire (Fri, Nov 13)

•	MedaSorb Technologies Corporation Announces Q3 2009 Results and Files Form 10-Q, Quarterly Report
	Marketwire (Fri, Nov 13)

•	MEDASORB TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	MEDASORB TECHNOLOGIES CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Fina
	EDGAR Online (Fri, Oct 9)

•	MedaSorb Technologies Corporation Raises $1.3M in Series B Warrant Exercise
	Marketwire (Fri, Oct 9)

More Headlines for MSBT.OB...

BUSINESS SUMMARY

MedaSorb Technologies Corporation, a development stage medical device company, engages in the research and development of an adsorbent platform technology for removal of toxins from blood and physiologic fluids.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

MedaSorb Technologies Corporation (MSBT.OB)